“…Ten antiangiogenic drugs (seven small kinase inhibitors, two antibodies, and one fusion protein) are approved by Food and Drug Administration for multiple cancer indicators (Jayson, Kerbel, Ellis, & Harris, ). Currently, exploring antiangiogenic agent from natural products is emerging as an important research field, and many antiangiogenic natural products with diverse molecular structures have been discovered (Guan, Liu, Luan, et al, ; Guan, Luan, Lu, et al, ; Huang, Liang, Wang, et al, ; Huang, Wang, Liang, et al, ; Luan, Gao, Guan, et al, ; Wang, Chung, Zhang, et al, ).…”